21, 2025, the FDA announced that the semaglutide shortage was over and that compounding pharmacies need to stop making and selling semaglutide injection products that are copies of FDA-approved products (Ozempic, Wegovy, and Rybelsus)
Sheela Magge, director of pediatric endocrinology at Johns Hopkins Medicine in Baltimore, has seen an increase in cases of more severe obesity-related conditions in children, including non-alcoholic fatty liver disease
JULIA: Hola, Laura
The main products of decomposition of persulfides include thiols, polysulfides and elemental sulfur (S 8 )
This mechanism contributes to increased satiety and reduced appetite, which can support weight managementa beneficial effect for many patients with type 2 diabetes, though Ozempic is not licensed specifically for weight management (Wegovy is the licensed semaglutide product for weight management)
Similar protective effects were observed with DFO (Fig